Abeona Therapeutics ABEO
NASDAQ ABEO
$5.03 +0.02 (+0.40%)
At close: Oct 2, 2026 · 4:00 PM EDT

Abeona Therapeutics (ABEO) Selling, General & Administrative (2011 - 2026)

Updated

Abeona Therapeutics' Selling, General & Administrative came in at $15.84 million for Q2 2026, down 7.7% from $17.15 million a year earlier and down 18.8% from the prior quarter.

Analysis

Abeona Therapeutics (ABEO) Selling, General & Administrative (2011 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Abeona Therapeutics reported Selling, General & Administrative of $73.43 million, up 79.0% year-over-year; for FY2025, it came in at $65.03 million, up 117.9% from FY2024.

  • Selling, General & Administrative has increased in each of the last three years, with a five-year compound annual growth rate of 22.3% (FY2020 to FY2025).
  • Going back by year, Selling, General & Administrative was $29.85 million in FY2024 (+57.1%), $19 million in FY2023 (+10.1%), $17.26 million in FY2022 (-20.3%) and $21.64 million in FY2021 (-9.0%).
  • The Q2 2026 figure represents the lowest quarterly Selling, General & Administrative since Q1 2025.
  • Year-over-year, Selling, General & Administrative increased in seven of the last eight quarters, with growth averaging 82.4%.
  • The fastest year-over-year change in Selling, General & Administrative over five years came in Q3 2025 (growth of 201.6%), and the weakest in Q4 2021 (a decline of 40.7%).
  • Business Quant data shows ABEO's Selling, General & Administrative at $19.5 million (Q1 2026), $18.78 million (Q4 2025) and $19.31 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) SG&A (Qtr)
1 Eli Lilly 1,082.65 Bn 1,051.23 Bn 19.71 Bn 3.43 Bn
2 Johnson & Johnson 623.68 Bn 542.21 Bn 17.26 Bn 6.43 Bn
3 AbbVie 459.43 Bn 432.59 Bn 12.70 Bn 3.63 Bn
4 Merck 354.80 Bn 309.23 Bn 12.21 Bn 2.90 Bn
5 Novartis Ag 269.16 Bn 225.03 Bn 11.24 Bn -3.24 Bn
6 Astrazeneca 244.40 Bn 217.97 Bn 12.86 Bn -5.65 Bn
7 Amgen 220.17 Bn 175.57 Bn 7.24 Bn 1.75 Bn
8 Gilead Sciences 183.05 Bn 157.16 Bn 6.22 Bn 1.92 Bn
9 Pfizer 160.27 Bn 107.22 Bn 10.94 Bn 3.41 Bn
10 Abeona Therapeutics 286.70 Mn -427.25 Mn 7.20 Mn 15.84 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 15.84 Mn
Mar 31, 2026 19.50 Mn
Dec 31, 2025 18.78 Mn
Sep 30, 2025 19.31 Mn
Jun 30, 2025 17.15 Mn
Mar 31, 2025 9.79 Mn
Dec 31, 2024 7.68 Mn
Sep 30, 2024 6.40 Mn
Jun 30, 2024 8.65 Mn
Mar 31, 2024 7.12 Mn
Dec 31, 2023 5.83 Mn
Sep 30, 2023 4.16 Mn
Jun 30, 2023 5.02 Mn
Mar 31, 2023 4.00 Mn
Dec 31, 2022 5.68 Mn
Sep 30, 2022 3.89 Mn
Jun 30, 2022 3.46 Mn
Mar 31, 2022 4.22 Mn
Dec 31, 2021 4.38 Mn
Sep 30, 2021 5.82 Mn
API Access

Abeona Therapeutics Selling, General & Administrative API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=ABEO&period=max&api_key=YOUR_API_KEY